Latest Insider Transactions at Cor Medix Inc. (CRMD)
This section provides a real-time view of insider transactions for Cor Medix Inc. (CRMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CorMedix Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CorMedix Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2022
|
Joseph Todisco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+4.4%
|
$30,000
$3.38 P/Share
|
|
May 10
2022
|
Joseph Todisco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
207,469
+50.0%
|
-
|
|
Dec 27
2021
|
Myron Kaplan Director |
SELL
Bona fide gift
|
Direct |
35,000
-5.36%
|
-
|
|
Dec 06
2021
|
Matthew T David Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+24.1%
|
$8,000
$4.5 P/Share
|
|
Nov 17
2021
|
Matthew T David Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+31.75%
|
$5,000
$5.07 P/Share
|
|
Nov 16
2021
|
Myron Kaplan Director |
BUY
Open market or private purchase
|
Direct |
10,000
+5.4%
|
$50,000
$5.14 P/Share
|
|
May 21
2021
|
Elizabeth Masson Hurlburt EVP |
SELL
Open market or private sale
|
Direct |
8,000
-100.0%
|
$48,000
$6.92 P/Share
|
|
May 17
2021
|
Myron Kaplan Director |
BUY
Open market or private purchase
|
Direct |
15,000
+8.33%
|
$90,000
$6.03 P/Share
|